Activity of telithromycin against multi-drug resistant Streptococcus pneumoniae and molecular characterization of macrolide and tetracycline resistance determinants

被引:8
作者
Cascone, C [1 ]
Mezzatesta, ML [1 ]
Santagati, M [1 ]
Cafiso, V [1 ]
Nicoletti, G [1 ]
Stefani, S [1 ]
机构
[1] Univ Catania, Dept Microbiol Sci, I-95124 Catania, Italy
关键词
multi-drug resistance; S.pneumoniae; telithromycin; macrolide-resistance genes;
D O I
10.1179/joc.2005.17.5.502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The antistreptococcal activity of telithromycin and 11 different comparators was evaluated in 26 multi-drug resistant (MDR) Streptococcus pneumoniae strains collected during 2002-2003 as part of the ongoing PROTEKT (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin) Italian Surveillance Program. The strains were characterized for their susceptibility to antibiotics both at the phenotypic and genotypic levels; furthermore, the association of erm(B), mef(A) class and tet(M) genes, as well as the mobile elements carrying them were determined. The strains in this study were resistant to penicillin (MIC >= 2 mg/l) in 23.1% of cases, resistant to tetracycline in 88.4%, to cotrimoxazole in 34.6% and cefuroxime in 26.9% while only telithromycin and levofloxacin retained 100% activity against all microorganisms. Co-existence of different resistance determinants was found in 19.2% of all isolates collected in our laboratory, coming from southern Italy. Twenty-three isolates showing the MLSB phenotype of resistance possessing the erm(B) gene (88.5%), associated with tet(M), were carried on the same Tn1545-like element, while two isolates showing the M phenotype possessing the mef(A) gene alone, were carried on Tn.1207.1. In only one strain were mef(E) and tet(M) together carried on Tn2009.
引用
收藏
页码:502 / 508
页数:7
相关论文
共 24 条
[1]  
[Anonymous], M7A6 CLSI
[2]  
[Anonymous], J ANTIMICROB CH
[3]  
Balfour JAB, 2001, DRUGS, V61, P815
[4]   Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US study [J].
Brown, SD ;
Farrell, DJ ;
Morrissey, I .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (11) :4980-4987
[5]   Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes [J].
Cascone, C ;
Santagati, M ;
Noviello, S ;
Iannelli, F ;
Esposito, S ;
Pozzi, G ;
Stefani, S .
MICROBIAL DRUG RESISTANCE, 2002, 8 (02) :129-132
[6]   Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae [J].
Del Grosso, M ;
d'Abusco, AS ;
Iannelli, F ;
Pozzi, G ;
Pantosti, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2037-2042
[7]   Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin [J].
Felmingham, D ;
Reinert, RR ;
Hirakata, Y ;
Rodloff, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 :25-37
[8]   Increased antibiotic resistance in respiratory tract pathogens: PROTEKT US - An update [J].
Karchmer, AW .
CLINICAL INFECTIOUS DISEASES, 2004, 39 :S142-S150
[9]   Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy [J].
Marchese, A ;
Tonoli, E ;
Balistreri, G ;
Debbia, E ;
Schito, GC .
MICROBIAL DRUG RESISTANCE, 2000, 6 (02) :163-170
[10]   Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy [J].
Marchese, A ;
Tonoli, E ;
Debbia, EA ;
Schito, GC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) :461-464